首页 | 本学科首页   官方微博 | 高级检索  
     


Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice
Authors:Menno Hoekstra  Joya E. Nahon  Laura M. de Jong  Mara J. Kröner  Lidewij R. de Leeuw  Miranda Van Eck
Affiliation:Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Gorlaeus Laboratories, Einsteinweg 55, 2333CC Leiden, the Netherlands.
Abstract:
Keywords:Corresponding author.  ABC transporter  ATP-binding cassette transporter  ACC1  acetyl-CoA carboxylase 1  ADMA  asymmetric dimethylarginine  ALT  alanine aminotransferase  ApoE  apolipoprotein E  cCIMT  common Carotid Intima-Media Thickness  FAS  fatty acid synthase  LPL  lipoprotein lipase  LXR  liver X receptor  MCP1  monocyte chemoattractant protein 1  oxLDL  oxidized LDL  PRMT3  protein arginine methyltransferase 3  SDMA  symmetric dimethylarginine  SREBP-1c  sterol regulatory element-binding protein-1c  SCD1  stearoyl-coenzyme A desaturase 1  TNFα  tumor necrosis factor alpha  UCP1  uncoupling protein 1  Protein arginine methyltransferase  Atherosclerosis  Fatty liver disease  Hepatic steatosis  Pharmacological inhibition  Mouse model
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号